alexa Wortmannin selectively enhances radiation-induced apoptosis in proliferative but not quiescent cells.
Cardiology

Cardiology

Atherosclerosis: Open Access

Author(s): Shi YQ, Blattmann H, Crompton NE

Abstract Share this page

Abstract PURPOSE: To examine whether wortmannin enhances radiation-induced apoptosis in human lymphoid cells. METHODS AND MATERIALS: Different concentrations of wortmannin (0-40 micrOM) were added to TK6 lymphoblastoid cell and whole blood cell cultures 15 min before irradiation (0-6-Gy X-rays). After irradiation, medium was changed and cells were left to incubate for 48 h. In blood samples, CD4, CD8, and CD20 lymphocytes were labeled using FITC-conjugated antibodies. All cell types were fixed in a diethyleneglycol-formaldehyde solution. DNA was stained with propidium iodide. Apoptosis was quantified using flow cytometry and confirmed using fluorescence microscopy. RESULTS: Wortmannin significantly enhances radiation-induced apoptosis in lymphoblastoid cells. Compared to the controls, wortmannin treatment only slightly enhanced radiation-induced apoptosis in quiescent T-lymphocytes and had no effect in quiescent B-lymphocytes. CONCLUSION: Wortmannin enhances radiation-induced apoptosis in a cell-type dependent manner. If the selective effect of wortmannin on proliferative tissues also exists in nonlymphoid tissues, it should enhance the therapeutic ratio of treatments for tumors located in poorly proliferative healthy tissues. Further studies are needed to compare the effects of wortmannin in human tumor cells and various normal cells including proliferative and quiescent cells.
This article was published in Int J Radiat Oncol Biol Phys and referenced in Atherosclerosis: Open Access

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords